OUT NOW: BioBoss interview with Abivax CEO Prof. Hartmut J. Ehrlich and his view on how to lead a biotech Company to get a molecule from scratch into Phase 3 clinical testing. Listen in! bioboss.buzzsprout.com/236855/1268228… #ulcerativecolitis #podcast #inflammation #leadership

Today we announced the implementation timeline for the consolidation of our ordinary shares, which was approved by shareholders at the EGM held on April 28, 2023. To learn more, please visit: relieftherapeutics.com/newsblog-detai… $RLF $RLFTF $RLFTY #rarediseases #metabolicdisorders

New #BioBoss podcast featuring Dario Neri, co-#founder and #CEO #Philogen, wyantsimboli.com/bioboss/dario-… #Leadership in #biopharma

BioBoss podcast wyantsimboli.com/bioboss/lisa-d… featuring Lisa Deschamps, #CEO AviadoBio. Hear Lisa speak with BioBoss host and Wyant Simboli principal John Simboli about #leadership in #biopharma. #BioBoss,#leadership,#innovation,#entrepreneurship,#biopharma,#biotech,#FTD,#ALS

New BioBoss podcast wyantsimboli.com/bioboss/anat-b… Anat Binur, co-founder, CEO, Ukko with BioBoss host and Wyant Simboli Group  Principal John Simboli on leadership #BioBoss,#leadership,#innovation,#entrepreneurship,#biopharma,#biotech,#technology,#CEO,#founder,#drugdevelopment,#foodallergy

BioBoss podcast lnkd.in/eHcdxSkS David Baram, founder CEO Emendo Bio. Hear David speak with BioBoss host and Wyant Simboli principal John Simboli on leadership in biopharma #RareDisease,#GeneticMedicine,#PrimeEditing,#nucleases,#GenomicMedicine,#PrecisionMedicine,#CRISPR

wyantsimboli.com/bioboss/mike-g… Mike Gaffney #CEO Cellphire Therapeutics, Inc. #leadership in #biotech; how Cellphire is working to save lives by bringing novel hemostatic products to patients in need. #platelet,#FPH,#hemostasis,#thrombosomes,#hepatocarcinoma,#nanomedicine,#StabilizedCellularTherapies

New #BioBoss #podcast wyantsimboli.com/bioboss/karine… featuring Karine Rossignol, co-founder #CEO of Smart Immune Smart Immune. #BioBoss,#leadership,#innovation,#entrepreneurship,#biopharma,#biotech,#technology, #oncology,#ThymeE,#thymus,#Tcell,#immunity,#cancer,#infection,#leukemia

Welcome to Season 7 of BioBoss wyantsimboli.com/bioboss/welcom…

S6 E67 Insights on Leadership: Listen to the full conversation between Mike Gaffney, CEO of Cellphire Therapeutics, Inc. and Wyant Simboli Group principal John Simboli at wyantsimboli.com/bioboss

S1 E11 Insights on Leadership: Listen to the full conversation between Liang Schweizer, Founder, Chairperson and CEO of HiFiBiO Therapeutics and Wyant Simboli Group principal John Simboli at wyantsimboli.com/bioboss

New #BioBoss #podcast wyantsimboli.com/bioboss/vlad-v… featuring Vlad Vitoc, MD, MBA, founder and #CEO of MAIA Biotechnology, Inc.. Hear Vlad speak about leadership and about how MAIA is working to develop and deliver innovative medicines to improve and extend the lives of people living with cancer.

Jorge Santos da Silva: Co-Founder and CEO of MoonLake Immunotherapeutics wyantsimboli.com/bioboss/jorge-…

New BioBoss podcast wyantsimboli.com/bioboss/jorge-… with Jorge Santos da Silva, co-founder and CEO of MoonLake Immunotherapeutics (NASDAQ: MLTX). Hear Jorge speak with BioBoss host and Wyant Simboli Group principal John Simboli about how MoonLake is working to develop therapies for people living with inflammatory diseases.

New BioBoss podcast at wyantsimboli.com/bioboss/geoffr… featuring Geoffrey Dow, #CEO of 60 Degrees Pharmaceuticals. Hear Geoffrey speak with Wyant Simboli Group principal John Simboli about how 60 Degrees is working to develop vital #medicines to treat and prevent #infectiousdiseases.

New BioBoss podcast at wyantsimboli.com/bioboss/derek-… featuring Derek Adams, CEO of Stellular Bio. Hear Derek speak with BioBoss host and Wyant Simboli Group principal John Simboli about leadership in biopharma and how Stellular Bio is working to expand the reach of regenerative medicine.

New BioBoss podcast at podcasts.apple.com/us/podcast/bio… and wyantsimboli.com/bioboss/abbas-… featuring Abbas Kazimi, CEO of Nimbus Therapeutics. Hear Abbas speak with John Simboli about how Nimbus is working to design and develop small molecule medicines capable of improving patients' lives.

New BioBoss podcast at wyantsimboli.com/bioboss/eduard… featuring Eduardo Bravo, CEO of Citryll. Hear Eduardo speak with BioBoss host and Wyant Simboli Group principal John Simboli about how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.

New BioBoss podcast at wyantsimboli.com/bioboss/todd-h… featuring Todd Harris, CEO of Tyra Biosciences. Todd speaks with BioBoss host and Wyant Simboli Group principal John Simboli about how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.